ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds

December 28, 2007

Univ. Of Pennsylvania Ordered to Review all NIH Research

October 11, 1985

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002